BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15313390)

  • 1. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs.
    Mazure NM; Brahimi-Horn MC; Berta MA; Benizri E; Bilton RL; Dayan F; Ginouvès A; Berra E; Pouysségur J
    Biochem Pharmacol; 2004 Sep; 68(6):971-80. PubMed ID: 15313390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
    Jaakkola P; Mole DR; Tian YM; Wilson MI; Gielbert J; Gaskell SJ; von Kriegsheim A; Hebestreit HF; Mukherji M; Schofield CJ; Maxwell PH; Pugh CW; Ratcliffe PJ
    Science; 2001 Apr; 292(5516):468-72. PubMed ID: 11292861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of hypoxia-induced transcription in normoxia.
    Hägg M; Wennström S
    Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
    Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
    EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
    Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
    Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
    Tanimoto K; Makino Y; Pereira T; Poellinger L
    EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell biology. How cells endure low oxygen.
    Marx J
    Science; 2004 Mar; 303(5663):1454-6. PubMed ID: 15001751
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
    Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ
    IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OS-9: another piece in the HIF complex story.
    Flashman E; McDonough MA; Schofield CJ
    Mol Cell; 2005 Feb; 17(4):472-3. PubMed ID: 15721249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation.
    D'Angelo G; Duplan E; Boyer N; Vigne P; Frelin C
    J Biol Chem; 2003 Oct; 278(40):38183-7. PubMed ID: 12876291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1's relationship to oxygen: simple yet sophisticated.
    Maxwell PH
    Cell Cycle; 2004 Feb; 3(2):156-9. PubMed ID: 14712080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proline hydroxylation and gene expression.
    Kaelin WG
    Annu Rev Biochem; 2005; 74():115-28. PubMed ID: 15952883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity.
    Mahon PC; Hirota K; Semenza GL
    Genes Dev; 2001 Oct; 15(20):2675-86. PubMed ID: 11641274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.
    Yu F; White SB; Zhao Q; Lee FS
    Cancer Res; 2001 May; 61(10):4136-42. PubMed ID: 11358837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From erythropoietin to oxygen: hypoxia-inducible factor hydroxylases and the hypoxia signal pathway.
    Ratcliffe PJ
    Blood Purif; 2002; 20(5):445-50. PubMed ID: 12207089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pVHL-hIF-1 system. A key mediator of oxygen homeostasis.
    Maxwell PH; Pugh CW; Ratcliffe PJ
    Adv Exp Med Biol; 2001; 502():365-76. PubMed ID: 11950150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF hydroxylation and the mammalian oxygen-sensing pathway.
    Safran M; Kaelin WG
    J Clin Invest; 2003 Mar; 111(6):779-83. PubMed ID: 12639980
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.
    Callapina M; Zhou J; Schnitzer S; Metzen E; Lohr C; Deitmer JW; Brüne B
    Exp Cell Res; 2005 May; 306(1):274-84. PubMed ID: 15878351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.